Masami Nakai

7PUBLICATIONS
13CO-AUTHORS
Epidemiological methodsBehavioural epidemiologyPharmacogenomicsTraditional Chinese medicine and treatmentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 08, 2026
Impact of dementia severity on efficacy of brexpiprazole for agitation in Alzheimer's dementia: A post hoc analysis of a randomized, double-blind, placebo-controlled study in Japan.

|Apr 28, 2025
Long-term safety and tolerability of brexpiprazole for Japanese patients with agitation in Alzheimer's disease dementia: A multicenter, open-label study.

Yu Nakamura, Jun Adachi, Naoki Hirota

|Sep 02, 2024
Effects of fremanezumab on migraine-associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double-blind, placebo-controlled trial.

Muneto Tatsumoto, Miki Ishida, Katsuhiro Iba

|Aug 21, 2023
Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trials.

Yasuhiko Matsumori, Miki Ishida, Katsuhiro Iba

|May 24, 2023
Fremanezumab for Episodic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.

Kazumasa Saigoh, Takao Takeshima, Masami Nakai

|Apr 27, 2023
Fremanezumab for Chronic Migraine Prevention in Japanese Patients: Subgroup Analysis from Two International Trials.

Kazumasa Saigoh, Takao Takeshima, Masami Nakai

Pageof 2

Frequent Collaborators

3 joint publications

Nobuyuki Koga

2 joint publications

Jun Adachi

2 joint publications

Naoki Hirota

2 joint publications

Koichi Shimizu